We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.2B
AUM Growth
+$4.78B
Cap. Flow
+$3.57B
Cap. Flow %
23.39%
Top 10 Hldgs %
44.86%
Holding
2,187
New
553
Increased
436
Reduced
404
Closed
789

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$95.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$89.4M
3
XOM icon
ExxonMobil
XOM
+$84.7M
4
SO icon
Southern Company
SO
+$79.2M
5
EMR icon
Emerson Electric
EMR
+$61.3M

Sector Composition

Rank Sector Weight
1 Technology 9.26%
2 Industrials 7.84%
3 Utilities 7.6%
4 Healthcare 5.4%
5 Real Estate 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
1401
Acadia Pharmaceuticals
ACAD
$5.07B
-276,829
Closed -$5.77M
ACDC icon
1402
ProFrac Holding
ACDC
$867M
-54,102
Closed -$589K
ACCO icon
1403
Acco Brands
ACCO
$391M
-14,876
Closed -$85K
ACHC icon
1404
Acadia Healthcare
ACHC
$2.63B
-20,959
Closed -$1.47M
ACLX
1405
DELISTED
Arcellx
ACLX
-37,952
Closed -$1.36M
ACRS icon
1406
Aclaris Therapeutics
ACRS
$908M
-146,454
Closed -$1M
ADC icon
1407
Agree Realty
ADC
$9.23B
-51,026
Closed -$2.82M
ADI icon
1408
Analog Devices
ADI
$178B
-14,620
Closed -$2.56M
ADM icon
1409
Archer Daniels Midland
ADM
$38.2B
-100,467
Closed -$7.58M
ADNT icon
1410
Adient
ADNT
$1.52B
-38,059
Closed -$1.4M
AEE icon
1411
Ameren
AEE
$29.4B
-83,054
Closed -$6.21M
AEP icon
1412
American Electric Power
AEP
$65.5B
-35,992
Closed -$2.71M
AGCO icon
1413
AGCO
AGCO
$7.65B
-32,463
Closed -$3.84M
AGL icon
1414
Agilon Health
AGL
$1.62B
-1,043
Closed -$463K
AHCO icon
1415
AdaptHealth
AHCO
$747M
-75,019
Closed -$683K
AHRT
1416
AH Realty Trust
AHRT
$502M
-61,140
Closed -$626K
AIG icon
1417
American International
AIG
$40.6B
-119,052
Closed -$7.21M
AIT icon
1418
Applied Industrial Technologies
AIT
$12.4B
-1,520
Closed -$235K
AKR icon
1419
Acadia Realty Trust
AKR
$2.9B
-113,280
Closed -$1.63M
ALE
1420
DELISTED
Allete
ALE
-87,391
Closed -$4.61M
ALG icon
1421
Alamo Group
ALG
$2.03B
-2,888
Closed -$499K
ALKS icon
1422
Alkermes
ALKS
$8.04B
-101,647
Closed -$2.85M
AM icon
1423
Antero Midstream
AM
$10.4B
-387,798
Closed -$4.65M
AMAT icon
1424
Applied Materials
AMAT
$381B
-96,494
Closed -$13.4M
AMC icon
1425
CALL
AMC Entertainment Holdings
AMC
$2.4B
-100,000
Closed -$798K

Similar funds

Michael Gelband's Q4 2023 Portfolio in Review

As of Q4 2023, Michael Gelband held 2,187 positions worth $15.2B, up 46% from $10.5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Michael Gelband deployed $3.57B of net new capital in Q4 2023, opening 553 new positions and adding to 436 existing holdings. Its largest new stake was Fidelity National Information Services: 6,650,397 shares worth $399M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 10% a quarter earlier, followed by Industrials and Utilities.

On the sell side, the largest reduction was Merck, an estimated $48.2M trimmed.

  • Michael Gelband's largest Q4 2023 buy was Fidelity National Information Services: 6,650,397 shares worth $399M.
  • Michael Gelband added most to Global Payments in Q4 2023, an estimated $250M increase.
  • Michael Gelband's biggest Q4 2023 reduction was Merck, cutting an estimated $48.2M.
  • Michael Gelband fully exited VMware, Inc in Q4 2023, selling an estimated $95.7M.
  • Michael Gelband's ten largest holdings make up 45% of its $15.2B portfolio in Q4 2023.
  • Michael Gelband opened 553 new positions and closed 789 in Q4 2023.
  • Michael Gelband's portfolio value rose 46% quarter-over-quarter to $15.2B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.